Stocks · Healthcare · Biotechnology
Omeros Corporation OMER
$18.61 +0.76% Close, Oct 2, 2026 · NASDAQ · Market cap $1.35B
Strong trend
Next earnings report: Nov 12, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- The diluted share count rose 53.0% in a year.
- Over the past year the stock returned +349.5%, ahead of the S&P 500 by 334.4 percentage points.
- The shares trade at 10.8× trailing earnings, higher than 90% of the company's own readings over the past five years.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalBottom 41%
- Gross marginTop 12%
- Operating marginBottom 24%
- Cash conversion (OCF / net income)Bottom 4%
- Accruals (lower is better)Bottom 1%
- Net debt / EBITDA (lower is better)Top 43%
- Interest coverBottom 45%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 4%
- Free-cash-flow yieldBottom 49%
- EBITDA / enterprise valueTop 10%
- Sales / enterprise valueBottom 14%
- P/E vs own 5-year history (lower is better)Bottom 12%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthTop 3%
- 6-month returnTop 14%
- 1-year return vs S&P 500Top 3%
- Distance from 52-week highTop 19%
- Trend checklist (0–4)Top 20%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersTop 4%
- Consecutive EPS beatsTop 15%
- Share of analysts rating BuyBottom 28%
- Upside to consensus price targetBottom 43%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Bottom 18%
- Maximum drawdown, 3 yearsBottom 41%
- Beta vs S&P 500 (lower is better)Bottom 39%
- Net debt / EBITDA (lower is better)Top 43%
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Gross margin | 95.8% | — | Top 12% | |
| Operating margin | -189.5% | — | Bottom 24% | |
| Net margin | 324.9% | — | — | |
| Free-cash-flow margin | -178.9% | — | — | |
| Return on invested capital | -31.1% | — | Bottom 41% |
Quality of earnings and balance sheet
- Cash conversion (OCF / net income)Above 1× means profits are backed by cash.
- -0.55×
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- 67.5%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 13.8%
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- 0.60×
- Interest cover (operating income / interest)How many times operating profit covers interest.
- -3.3×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- -3.39%
- Shareholder yield
- -3.39%
- Share count change, 1 year
- +53.0%
- Share count change, 3-year CAGR
- +12.6%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 12, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 5
- Beats in the last 8 reports
- 7 of 8
- Average EPS surprise, last 4
- +100.0%
- Average 2-day reaction, last 8
- +1.9%
- Positive 20 days after report
- 4 of 8
Analysts
- Consensus price target
- $27.50
- Target vs current price
- +47.8%
- Analysts with a rating
- 19
- Share rating Buy or Strong Buy
- 63%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 13, 2026 | +155.9% | +26.5% | +34.1% | +35.6% | — |
| May 13, 2026 | +40.0% | -2.6% | -18.9% | -30.9% | -10.2% |
| Mar 31, 2026 | +670.9% | +7.6% | +11.9% | +49.5% | +9.3% |
| Nov 13, 2025 | +19.0% | -8.9% | +19.3% | +53.7% | +62.1% |
| Aug 14, 2025 | +21.8% | -3.5% | -1.9% | -1.6% | +54.1% |
| May 15, 2025 | -2.5% | +0.5% | -20.9% | -9.7% | +5.3% |
| Mar 31, 2025 | +30.4% | -3.0% | -16.6% | -14.2% | -58.7% |
| Nov 13, 2024 | +20.0% | -1.6% | +41.5% | +111.5% | +104.7% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 13, 2026 | $0.15 | -$0.27 | +155.9% | $28.5M |
| May 13, 2026 | -$0.24 | -$0.40 | +40.0% | $9.9M |
| Mar 31, 2026 | $3.14 | -$0.55 | +670.9% | — |
| Nov 13, 2025 | -$0.47 | -$0.58 | +19.0% | — |
| Aug 14, 2025 | -$0.43 | -$0.55 | +21.8% | — |
| May 15, 2025 | -$0.58 | -$0.57 | -2.5% | — |
| Mar 31, 2025 | -$0.54 | -$0.78 | +30.4% | — |
| Nov 13, 2024 | -$0.56 | -$0.70 | +20.0% | — |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| P/E (trailing) | 10.8× | 4.5× | 90th | Top 4% |
| P/E (forward) | 20.5× | — | — | — |
| EV / EBITDA | 10.5× | — | — | Top 10% |
| EV / Sales | 37.18× | — | — | Bottom 14% |
| Free-cash-flow yield | -5.10% | — | — | Bottom 49% |
| Earnings yield | 9.24% | — | — | Top 4% |
P/E over the past five years
Range 0.9× – 12.6× since Dec 31, 2021. Each point: price on the filing date divided by trailing-twelve-month EPS known then.
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✓ Price above 50-day average
- ✓ Price above 200-day average
- ✓ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 49
- Days above the 200-day average
- 49
- 50-day average slope (20 days)
- +27.0%
- 200-day average slope (20 days)
- +7.5%
- Distance from 50-day average
- +9.9%
- Distance from 200-day average
- +43.2%
- RSI (14)
- 51.2
- Relative volume
- 0.64×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 80.0%
- Volatility vs own 5-year history
- 22th percentile · Normal for this stock
- Beta vs S&P 500 (2 years, weekly)
- 1.31
- Correlation with S&P 500
- 0.15
- Current drawdown from 1-year high
- -11.6%
- Maximum drawdown, 3 years
- -75.6%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Feb 19, 2021 | Oct 27, 2023 | -95.4% | 677 days | Not yet recovered |
| Oct 16, 2020 | Oct 30, 2020 | -12.0% | 10 days | 10 days (Nov 13, 2020) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $1.35B
- P/E (TTM)
- 10.8
- EPS, diluted (TTM)
- $1.72
- Revenue (TTM)
- $38.4M
- 52-week range
- $4.06 – $21.24
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| Gross profit | -$1.4M | $0 | $0 | $0 | $0 |
| Operating income | -$173.6M | -$163.4M | -$164.5M | -$169.3M | -$122.8M |
| Net income | -$111.4M | $47.4M | -$117.8M | -$156.8M | -$3.4M |
| EPS (diluted) | -$1.79 | $0.46 | -$1.88 | -$2.70 | -$0.05 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $9.9M | $28.5M |
| Net income | -$32.2M | -$31.4M | -$33.5M | -$25.4M | -$30.9M | $86.5M | $56.1M | $13.2M |
| EPS (diluted) | -$0.56 | -$0.54 | -$0.58 | -$0.43 | -$0.47 | $1.42 | $0.62 | $0.15 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | -$109.7M | -$86.5M | $74.7M | -$148.8M | -$116.1M |
| Capital expenditure | -$277,000 | -$113,000 | -$426,000 | -$165,000 | -$65,000 |
| Free cash flow | -$110.0M | -$86.6M | $74.3M | -$149.0M | -$116.2M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | $8.4M | $415,000 | -$4.7M | -$11.9M | $47.0M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $132.0M
- Total assets
- $286.8M
- Total liabilities
- $338.2M
- Total debt
- $83.8M
- Net debt
- $81.8M
- Shareholders’ equity
- -$51.3M
As of Jun 30, 2026 (filed Aug 12, 2026).
Short interest
- Shares sold short
- 12,491,576
- Days to cover
- 9.31
- Change vs previous report
- -2.1%
FINRA short interest, settlement date Sep 15, 2026.